Journal of Oncology Practice, Vol 4, No 6 (November), 2008: pp. 289-295
© 2008
American Society of Clinical Oncology.
DOI: 10.1200/JOP.0866002
Informed Consent for Chemotherapy: ASCO Member Resources
Courtney Storm, JD, MBE,
Jacqueline Casillas, MD,
Hans Grunwald, MD,
Dianna S. Howard, MD,
Kristen McNiff, MPH,
Michael M. Neuss, MD
Corresponding author: Kristen McNiff, MPH, Director, Quality Division, Department of Cancer Policy and Clinical Affairs, ASCO, 2318 Mill Rd, Suite 800, Alexandria, VA 22314; kristen.mcniff@asco.org
| Because this article has no abstract, we have provided an extract of the first 100 words of the full text.
|
Consent to treatment is an important part of the delivery of quality cancer care. Physician practices that participate in ASCO's Quality Oncology Practice Initiative (QOPI) and others expressed interest in having ASCO provide informed consent resources, and indicated that they would be more likely to use a consent form for chemotherapy if ASCO provided a template. Recent Journal of Oncology Practice articles outlining unique factors in consent for chemotherapy, documentation issues, and malpractice concerns also raised member interest. In response, members of ASCO's Ethics and Quality of Care Committees formed a joint working group to design a consent form template . . . [Click for More]
|